Jefferies Group’s GSK GSK Stock Holding History

Jefferies Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.18M	Buy	+40,000	New	+$1.52M	0.01%	768
2021 Q4	–	Sell	-18,400	Closed	-$879K	–	1777
2021 Q3	$879K	Buy	+18,400	New	+$924K	0.01%	1044
2018 Q3	–	Sell	-8,400	Closed	-$423K	–	2521
2018 Q2	$423K	Buy	+8,400	New	+$423K	﹤0.01%	1675
2016 Q1	–	Sell	-117,680	Closed	-$5.93M	–	2360
2015 Q4	$5.93M	Buy	117,680 +38,000	+48%	+$1.94M	0.03%	396
2015 Q3	$3.83M	Sell	79,680 -245,040	-75%	-$12.8M	0.02%	605
2015 Q2	$16.9M	Buy	+324,720	New	+$18.3M	0.09%	189
2015 Q1	–	Sell	-34,880	Closed	-$1.86M	–	2217
2014 Q4	$1.86M	Buy	+34,880	New	+$1.95M	0.01%	737
2014 Q1	–	Sell	-80,000	Closed	-$5.34M	–	2170
2013 Q4	$5.34M	Buy	80,000 +40,000	+100%	+$2.59M	0.03%	301
2013 Q3	$2.51M	Sell	40,000 -40,000	-50%	-$2.57M	0.02%	524
2013 Q2	$5M	Buy	+80,000	New	+$5.08M	0.05%	255

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jefferies Group's GSK Position: Q3 2022 in Review

Jefferies Group opened a new position in GSK (GSK) in Q3 2022: 298,662 shares worth $8.79M. The stake represents 0.07% of the portfolio and ranks #215 among its holdings. This is a return to the name: Jefferies Group previously reported a position in GSK as recently as Q4 2019.

Jefferies Group first reported a position in GSK in Q2 2013 and has held it in 16 quarters since. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

Jefferies Group held 298,662 shares of GSK worth $8.79M as of Q3 2022.
GSK was a new Jefferies Group position in Q3 2022.
GSK made up 0.07% of Jefferies Group's portfolio in Q3 2022, its #215 holding.
Jefferies Group first reported a position in GSK in Q2 2013 and has held it in 16 quarters since.
742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.